1001 Formate dehydrogenase/DMSO reductase, domain 1
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | 24 | 7.1 | 3.39× | q < 0.0001 | |
| Homogeneous metal compounds | 8 | 12.6 | 0.64× | q = 0.12 | |
| Homogeneous non-metal compounds | 2 | 5.5 | 0.36× | q = 0.20 | |
| Organic oxygen compounds | 0 | 5.1 | 0 | q = 0.01 | |
| Mixed metal/non-metal compounds | 2 | 0.5 | 3.71× | not tested | |
| Organoheterocyclic compounds | 2 | 4.0 | 0.51× | not tested | |
| Lipids and lipid-like molecules | 1 | 2.9 | 0.35× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03317 | HEC | Ferroheme C | 10 |
| DB07349 | AGA | (1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE | 8 |
| DB04137 | GTP | Guanosine-5'-Triphosphate | 3 |
| DB00157 | NAI | NADH | 2 |
| DB18509 | AST | Arsenite ion | 2 |
| DB04315 | GDP | Guanosine-5'-Diphosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| SF4 | IRON/SULFUR CLUSTER | 218 |
| MGD | 2-AMINO-5,6-DIMERCAPTO-7-METHYL-3,7,8A,9-TETRAHYDRO-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-4-ONE GUANOSINE DINUCLEOTIDE | 184 |
| F3S | FE3-S4 CLUSTER | 40 |
| MD1 | PHOSPHORIC ACID 4-(2-AMINO-4-OXO-3,4,5,6,-TETRAHYDRO-PTERIDIN-6-YL)-2-HYDROXY-3,4-DIMERCAPTO-BUT-3-EN-YL ESTER GUANYLATE ESTER | 31 |
| PGD | 2-AMINO-5,6-DIMERCAPTO-7-METHYL-3,7,8A,9-TETRAHYDRO-8-OXA-1,3,9,10-TETRAAZA-ANTHRACEN-4-ONE GUANOSINE DINUCLEOTIDE | 13 |
| HEC | HEME C | 10 |
| AGA | (1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE | 8 |
| NAmetal | SODIUM ION | 7 |
| SO3 | SULFITE ION | 6 |
| ZNmetal | ZINC ION | 6 |
| MOmetal | MOLYBDENUM ATOM | 5 |
| CAmetal | CALCIUM ION | 4 |
| CL | CHLORIDE ION | 4 |
| 6MOmetal | MOLYBDENUM(VI) ION | 3 |
| BSY | BISELENITE ION | 3 |
| MGmetal | MAGNESIUM ION | 3 |
| 3PH | 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE | 2 |
| ART | ARSENATE | 2 |
| AST | ARSENITE | 2 |
| CO2 | CARBON DIOXIDE | 2 |